Global Axitinib Sales Market Report Forecast 2017 to 2022

November 2017 | 130 pages | ID: GBFB24094AAEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 AXITINIB MARKET OVERVIEW

1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Axitinib
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Axitinib Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Axitinib (2012-2022)
  1.5.1 Global Axitinib Sales and Growth Rate (2012-2022)
  1.5.2 Global Axitinib Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON AXITINIB INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 AXITINIB MANUFACTURING COST ANALYSIS

3.1 Axitinib Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Axitinib

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Axitinib Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Axitinib Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL AXITINIB COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Axitinib Market Competition by Manufacturers
  5.1.1 Global Axitinib Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Axitinib Revenue and Share by Manufacturers (2012-2017)
5.2 Global Axitinib (Volume and Value) by Type
  5.5.1 Global Axitinib Sales and Market Share by Type (2012-2017)
  5.5.2 Global Axitinib Revenue and Market Share by Type (2012-2017)
5.3 Global Axitinib (Volume and Value) by Regions
  5.3.1 Global Axitinib Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Axitinib Revenue and Market Share by Regions (2012-2017)
5.4 Global Axitinib (Volume) by Application

6 UNITED STATES AXITINIB (VOLUME, VALUE AND SALES PRICE)

6.1 United States Axitinib Sales and Value (2012-2017)
  6.1.1 United States Axitinib Sales and Growth Rate (2012-2017)
  6.1.2 United States Axitinib Revenue and Growth Rate (2012-2017)
  6.1.3 United States Axitinib Sales Price Trend (2012-2017)
6.2 United States Axitinib Sales and Market Share by Manufacturers
6.3 United States Axitinib Sales and Market Share by Type
6.4 United States Axitinib Sales and Market Share by Application

7 CHINA AXITINIB (VOLUME, VALUE AND SALES PRICE)

7.1 China Axitinib Sales and Value (2012-2017)
  7.1.1 China Axitinib Sales and Growth Rate (2012-2017)
  7.1.2 China Axitinib Revenue and Growth Rate (2012-2017)
  7.1.3 China Axitinib Sales Price Trend (2012-2017)
7.2 China Axitinib Sales and Market Share by Manufacturers
7.3 China Axitinib Sales and Market Share by Type
7.4 China Axitinib Sales and Market Share by Application

8 EUROPE AXITINIB (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Axitinib Sales and Value (2012-2017)
  8.1.1 Europe Axitinib Sales and Growth Rate (2012-2017)
  8.1.2 Europe Axitinib Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Axitinib Sales Price Trend (2012-2017)
8.2 Europe Axitinib Sales and Market Share by Manufacturers
8.3 Europe Axitinib Sales and Market Share by Type
8.4 Europe Axitinib Sales and Market Share by Application

9 JAPAN AXITINIB (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Axitinib Sales and Value (2012-2017)
  9.1.1 Japan Axitinib Sales and Growth Rate (2012-2017)
  9.1.2 Japan Axitinib Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Axitinib Sales Price Trend (2012-2017)
9.2 Japan Axitinib Sales and Market Share by Manufacturers
9.3 Japan Axitinib Sales and Market Share by Type
9.4 Japan Axitinib Sales and Market Share by Application

10 GLOBAL AXITINIB MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Allergan
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Alnylam Pharmaceuticals
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Amgen
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Angstrom Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Acceleron Pharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Biocon
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Bionomics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 CASI Pharmaceuticals
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL AXITINIB MARKET FORECAST (2017-2022)

13.1 Global Axitinib Sales, Revenue Forecast (2017-2022)
13.2 Global Axitinib Sales Forecast by Regions (2017-2022)
13.3 Global Axitinib Sales Forecast by Type (2017-2022)
13.4 Global Axitinib Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Axitinib
Table Classification of Axitinib
Figure Global Sales Market Share of Axitinib by Type in 2016
Table Applications of Axitinib
Figure Global Sales Market Share of Axitinib by Application in 2016
Figure United States Axitinib Revenue and Growth Rate (2012-2022)
Figure China Axitinib Revenue and Growth Rate (2012-2022)
Figure Europe Axitinib Revenue and Growth Rate (2012-2022)
Figure Japan Axitinib Revenue and Growth Rate (2012-2022)
Figure Global Axitinib Sales and Growth Rate (2012-2022)
Figure Global Axitinib Revenue and Growth Rate (2012-2022)
Table Global Axitinib Sales of Key Manufacturers (2012-2017)
Table Global Axitinib Sales Share by Manufacturers (2012-2017)
Figure 2015 Axitinib Sales Share by Manufacturers
Figure 2016 Axitinib Sales Share by Manufacturers
Table Global Axitinib Revenue by Manufacturers (2012-2017)
Table Global Axitinib Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Axitinib Revenue Share by Manufacturers
Table 2016 Global Axitinib Revenue Share by Manufacturers
Table Global Axitinib Sales and Market Share by Type (2012-2017)
Table Global Axitinib Sales Share by Type (2012-2017)
Figure Sales Market Share of Axitinib by Type (2012-2017)
Figure Global Axitinib Sales Growth Rate by Type (2012-2017)
Table Global Axitinib Revenue and Market Share by Type (2012-2017)
Table Global Axitinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Axitinib by Type (2012-2017)
Figure Global Axitinib Revenue Growth Rate by Type (2012-2017)
Table Global Axitinib Sales and Market Share by Regions (2012-2017)
Table Global Axitinib Sales Share by Regions (2012-2017)
Figure Sales Market Share of Axitinib by Regions (2012-2017)
Figure Global Axitinib Sales Growth Rate by Regions (2012-2017)
Table Global Axitinib Revenue and Market Share by Regions (2012-2017)
Table Global Axitinib Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Axitinib by Regions (2012-2017)
Figure Global Axitinib Revenue Growth Rate by Regions (2012-2017)
Table Global Axitinib Sales and Market Share by Application (2012-2017)
Table Global Axitinib Sales Share by Application (2012-2017)
Figure Sales Market Share of Axitinib by Application (2012-2017)
Figure Global Axitinib Sales Growth Rate by Application (2012-2017)
Figure United States Axitinib Sales and Growth Rate (2012-2017)
Figure United States Axitinib Revenue and Growth Rate (2012-2017)
Figure United States Axitinib Sales Price Trend (2012-2017)
Table United States Axitinib Sales by Manufacturers (2012-2017)
Table United States Axitinib Market Share by Manufacturers (2012-2017)
Table United States Axitinib Sales by Type (2012-2017)
Table United States Axitinib Market Share by Type (2012-2017)
Table United States Axitinib Sales by Application (2012-2017)
Table United States Axitinib Market Share by Application (2012-2017)
Figure China Axitinib Sales and Growth Rate (2012-2017)
Figure China Axitinib Revenue and Growth Rate (2012-2017)
Figure China Axitinib Sales Price Trend (2012-2017)
Table China Axitinib Sales by Manufacturers (2012-2017)
Table China Axitinib Market Share by Manufacturers (2012-2017)
Table China Axitinib Sales by Type (2012-2017)
Table China Axitinib Market Share by Type (2012-2017)
Table China Axitinib Sales by Application (2012-2017)
Table China Axitinib Market Share by Application (2012-2017)
Figure Europe Axitinib Sales and Growth Rate (2012-2017)
Figure Europe Axitinib Revenue and Growth Rate (2012-2017)
Figure Europe Axitinib Sales Price Trend (2012-2017)
Table Europe Axitinib Sales by Manufacturers (2012-2017)
Table Europe Axitinib Market Share by Manufacturers (2012-2017)
Table Europe Axitinib Sales by Type (2012-2017)
Table Europe Axitinib Market Share by Type (2012-2017)
Table Europe Axitinib Sales by Application (2012-2017)
Table Europe Axitinib Market Share by Application (2012-2017)
Figure Japan Axitinib Sales and Growth Rate (2012-2017)
Figure Japan Axitinib Revenue and Growth Rate (2012-2017)
Figure Japan Axitinib Sales Price Trend (2012-2017)
Table Japan Axitinib Sales by Manufacturers (2012-2017)
Table Japan Axitinib Market Share by Manufacturers (2012-2017)
Table Japan Axitinib Sales by Type (2012-2017)
Table Japan Axitinib Market Share by Type (2012-2017)
Table Japan Axitinib Sales by Application (2012-2017)
Table Japan Axitinib Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Axitinib Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Axitinib Global Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Axitinib Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Axitinib Global Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Axitinib Global Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acceleron Pharma Axitinib Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Axitinib Global Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bionomics Axitinib Global Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Axitinib Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Axitinib
Figure Manufacturing Process Analysis of Axitinib
Figure Axitinib Industrial Chain Analysis
Table Raw Materials Sources of Axitinib Major Manufacturers in 2016
Table Major Buyers of Axitinib
Table Distributors/Traders List
Figure Global Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Global Axitinib Revenue and Growth Rate Forecast (2017-2022)
Table Global Axitinib Sales Forecast by Regions (2017-2022)
Table Global Axitinib Sales Forecast by Type (2017-2022)
Table Global Axitinib Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech